Zeke Capital Advisors, LLC Novo Nordisk A S Transaction History

Zeke Capital Advisors, LLC

$1.53 Billion
Q4 2022

A detailed history of Zeke Capital Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 15,127 shares of NVO stock, worth $1.59 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

15,127

Previous 16,697 9.4%

Holding current value

$1.59 Million

Previous $1.66 Million 23.09%

% of portfolio

0.13%

Previous 0.12%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $161,003 - $212,468	-1,570 Reduced 9.4%	15,127 $2.05 Million
Q2 2022 Aug 09, 2022	BUY	$103.24 - $121.81 $202,866 - $239,356	1,965 Added 13.34%	16,697 $1.86 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $113,395 - $137,073	1,218 Added 9.01%	14,732 $1.64 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $70,471 - $86,053	735 Added 5.75%	13,514 $1.51 Million
Q2 2021 Aug 16, 2021	BUY	$67.66 - $84.76 $64,074 - $80,267	947 Added 8.0%	12,779 $1.07 Million
Q1 2021 Apr 21, 2021	SELL	$67.06 - $75.82 $42,247 - $47,766	-630 Reduced 5.06%	11,832 $798,000
Q4 2020 Feb 10, 2021	BUY	$63.89 - $73.8 $164,963 - $190,551	2,582 Added 26.13%	12,462 $870,000
Q3 2020 Nov 09, 2020	BUY	$63.69 - $70.22 $1,464 - $1,615	23 Added 0.23%	9,880 $686,000
Q2 2020 Jul 21, 2020	SELL	$58.54 - $67.94 $1.03 Million - $1.2 Million	-17,674 Reduced 64.2%	9,857 $645,000
Q1 2020 Apr 24, 2020	SELL	$49.46 - $64.78 $464,478 - $608,348	-9,391 Reduced 25.43%	27,531 $1.66 Million
Q4 2019 Jan 17, 2020	SELL	$49.86 - $58.26 $2,891 - $3,379	-58 Reduced 0.16%	36,922 $2.14 Million
Q3 2019 Oct 18, 2019	BUY	$47.54 - $53.43 $26,955 - $30,294	567 Added 1.56%	36,980 $1.91 Million
Q2 2019 Jul 24, 2019	BUY	$46.79 - $52.47 $62,043 - $69,575	1,326 Added 3.78%	36,413 $1.86 Million
Q1 2019 Apr 29, 2019	BUY	$46.36 - $52.63 $146,219 - $165,995	3,154 Added 9.88%	35,087 $1.84 Million
Q4 2018 Feb 11, 2019	SELL	$41.54 - $47.25 $4.02 Million - $4.58 Million	-96,826 Reduced 75.2%	31,933 $1.47 Million
Q3 2018 Nov 08, 2018	BUY	$46.76 - $51.24 $163,332 - $178,981	3,493 Added 2.79%	128,759 $6.07 Million
Q2 2018 Jul 24, 2018	BUY	$44.29 - $50.42 $5.55 Million - $6.32 Million	125,266 New	125,266 $5.78 Million

Others Institutions Holding NVO

# of Institutions

1,954

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Account

Zeke Capital Advisors, LLC Novo Nordisk A S Transaction History